Marco Mor
Marco Mor
University of Parma, UniversitÓ degli Studi di Parma
Verified email at unipr.it
TitleCited byYear
Modulation of anxiety through blockade of anandamide hydrolysis
S Kathuria, S Gaetani, D Fegley, F Vali˝o, A Duranti, A Tontini, M Mor, ...
Nature medicine 9 (1), 76, 2003
13702003
Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy
HY Frank, M Mantegazza, RE Westenbroek, CA Robbins, F Kalume, ...
Nature neuroscience 9 (9), 1142, 2006
7042006
An endocannabinoid mechanism for stress-induced analgesia
AG Hohmann, RL Suplita, NM Bolton, MH Neely, D Fegley, R Mangieri, ...
Nature 435 (7045), 1108, 2005
6812005
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ...
Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005
6052005
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamideá…
D Fegley, S Gaetani, A Duranti, A Tontini, M Mor, G Tarzia, D Piomelli
Journal of Pharmacology and Experimental Therapeutics 313 (1), 352-358, 2005
4122005
Pharmacological profile of the selective FAAH inhibitor KDS‐4103 (URB597)
D Piomelli, G Tarzia, A Duranti, A Tontini, M Mor, TR Compton, O Dasse, ...
CNS drug reviews 12 (1), 21-38, 2006
3212006
Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress
M Bortolato, RA Mangieri, J Fu, JH Kim, O Arguello, A Duranti, A Tontini, ...
Biological psychiatry 62 (10), 1103-1110, 2007
2762007
Cyclohexylcarbamic acid 3 ‘-or 4 ‘-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: Synthesis, quantitative structure− activity relationships, andá…
M Mor, S Rivara, A Lodola, PV Plazzi, G Tarzia, A Duranti, A Tontini, ...
Journal of medicinal chemistry 47 (21), 4998-5008, 2004
2632004
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
JR Clapper, G Moreno-Sanz, R Russo, A Guijarro, F Vacondio, A Duranti, ...
Nature neuroscience 13 (10), 1265, 2010
2382010
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus
JK Makara, M Mor, D Fegley, SI Szabˇ, S Kathuria, G Astarita, A Duranti, ...
Nature neuroscience 8 (9), 1139, 2005
2292005
Design, synthesis, and structure− activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors
G Tarzia, A Duranti, A Tontini, G Piersanti, M Mor, S Rivara, PV Plazzi, ...
Journal of medicinal chemistry 46 (12), 2352-2360, 2003
1802003
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation
C Solorzano, C Zhu, N Battista, G Astarita, A Lodola, S Rivara, M Mor, ...
Proceedings of the National Academy of Sciences 106 (49), 20966-20971, 2009
1792009
The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice
R Russo, J LoVerme, G La Rana, TR Compton, J Parrott, A Duranti, ...
Journal of Pharmacology and Experimental Therapeutics 322 (1), 236-242, 2007
1702007
A catalytically silent FAAH-1 variant drives anandamide transport in neurons
J Fu, G Bottegoni, O Sasso, R Bertorelli, W Rocchia, M Masetti, A Guijarro, ...
Nature neuroscience 15 (1), 64, 2012
1672012
2-[N-Acylamino(C1−C3)alkyl]indoles as MT1 Melatonin Receptor Partial Agonists, Antagonists, and Putative Inverse Agonists
G Spadoni, C Balsamini, A Bedini, G Diamantini, B Di Giacomo, A Tontini, ...
Journal of medicinal chemistry 41 (19), 3624-3634, 1998
1031998
URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices
AR King, A Duranti, A Tontini, S Rivara, A Rosengarth, JR Clapper, ...
Chemistry & biology 14 (12), 1357-1365, 2007
982007
Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice
J LoVerme, A Duranti, A Tontini, G Spadoni, M Mor, S Rivara, N Stella, ...
Bioorganic & medicinal chemistry letters 19 (3), 639-643, 2009
942009
Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties
G Astarita, B Di Giacomo, S Gaetani, F Oveisi, TR Compton, S Rivara, ...
Journal of Pharmacology and Experimental Therapeutics 318 (2), 563-570, 2006
932006
Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study
M Mor, S Rivara, C Silva, F Bordi, PV Plazzi, G Spadoni, G Diamantini, ...
Journal of medicinal chemistry 41 (20), 3831-3844, 1998
851998
Clinical perspectives for irreversible tyrosine kinase inhibitors in cancer
C Carmi, M Mor, PG Petronini, RR Alfieri
Biochemical pharmacology 84 (11), 1388-1399, 2012
832012
The system can't perform the operation now. Try again later.
Articles 1–20